IFNA2 and non-small cell lung carcinoma: SI markers and pro-inflammatory cytokine (IL-17F and IFNα2) tend to be higher in NSCLC patients and the anti-inflammatory cytokine IL-1RA tends to be high in SCLC, which taken together suggests that NSCLC patients tend to have elevated levels of inflammation relative to those diagnosed with SCLC.